Targeting leucine-rich repeat kinase 2 in Parkinson's disease

By Chan Sharon L   Angeles Dario C   Tan Eng-King  

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 12, 2013-12 ,pp. : 1471-1482

Informa Healthcare

Access to resources Recommend Favorite

A new approach to Parkinson's disease: inhibition of leucine-rich repeat kinase-2

By Doggrell Sheila A  

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 4, 2011-04 ,pp. : 587-590

Informa Healthcare

Access to resources Recommend Favorite

Decreased sigmoidal ABCB1 (P-glycoprotein) expression in ulcerative colitis is associated with disease activity

By Ufer Mike   Hääsler Robert   Jacobs Gunnar   Haenisch Sierk   Läächelt Sandra   Faltraco Frank   Sina Christian   Rosenstiel Philip   Nikolaus Susanna   Schreiber Stefan   Cascorbi Ingolf  

Pharmacogenomics, Vol. 10, Iss. 12, 2009-12 ,pp. : 1941-1953

Future Medicine

Access to resources Recommend Favorite

Tumor Necrosis Factor Alpha in Ulcerative Colitis and Diverticular Disease Associated Colitis

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 7, Iss. 3, 2007-09 ,pp. : 187-194

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibitors of Leucine-Rich Repeat Kinase 2 (LRRK2): Progress and Promise for the Treatment of Parkinson’s Disease

By  

Current Topics in Medicinal Chemistry, Vol. 15, Iss. 10, 2015-05 ,pp. : 927-938

Bentham Science Publishers

Access to resources Recommend Favorite